top of page
Biotech PDUFAs to Watch March 2023 - CDTX, BMRN
Originally posted 2/9/2023; last updated 3/29/23
Feb 9, 2023
Â
Â
Â


Biopharma Daily Stock Updates - 06/13/22
$XBI $63.32 | -5.53% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX -10.7% Novavax COVID-19...
Jun 13, 2022
Â
Â
Â


Free Biopharma Daily Stock Updates - 06/13/22
$XBI $63.32 | -5.53% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX -10.7% Novavax COVID-19...
Jun 13, 2022
Â
Â
Â


Q1 2022 Baker bros Biotech Hedge Fund Update
At BPIQ we have started to track quarterly 13F filings for some of the largest biotech hedge funds. Q1 2022 13F filings were made on or...
May 18, 2022
Â
Â
Â
J.P. Morgan Healthcare Conference
The 40th Annual J.P. Morgan Health Care Conference is taking place fully online from January 10-13, 2022. "This premier conference is...
Dec 31, 2021
Â
Â
Â
Incyte (INCY) appears to have the stronger hand in its patent disputes with Concert (CNCE), regardle
BIopharma companies (Concert and Incyte) patent dispute.
Apr 8, 2019
Â
Â
Â
Incyte (INCY) appears to have the stronger hand in its patent disputes with Concert (CNCE), regardle
(For a longer version of this article, with more detailed legal facts, please CLICK HERE.) Concert (CNCE) and Incyte (INCY) have been...
Apr 8, 2019
Â
Â
Â
Jump start your biotech due diligence
Our platform helps you uncover your next biotech investment opportunity
bottom of page
